Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucosidase, alpha | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0044 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0 | 0.5 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0444 | 0.2658 | 0.9074 |
Echinococcus granulosus | neuropeptide s receptor | 0.0444 | 0.2658 | 0.9074 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.1551 | 1 | 1 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.0834 | 0.0834 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0028 | 0.0028 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0044 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0048 | 0.0028 | 0.0028 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.1015 | 0.3467 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0444 | 0.2658 | 0.9074 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0048 | 0.0028 | 0.0028 |
Onchocerca volvulus | 0.0114 | 0.0465 | 0.5 | |
Echinococcus granulosus | cyclin dependent kinase 7 | 0.0485 | 0.2929 | 1 |
Brugia malayi | cyclin-dependent kinase 7 homolog | 0.0485 | 0.2929 | 0.2929 |
Echinococcus granulosus | geminin | 0.0163 | 0.079 | 0.2698 |
Trypanosoma brucei | glucosidase, putative | 0.0044 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0485 | 0.2929 | 0.2929 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0 | 0.5 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.0834 | 0.0834 |
Schistosoma mansoni | hypothetical protein | 0.0163 | 0.079 | 0.079 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1551 | 1 | 1 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0044 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0 | 0.5 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0044 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0 | 0.5 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0197 | 0.1015 | 0.1015 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0044 | 0 | 0.5 |
Echinococcus multilocularis | cyclin dependent kinase 7 | 0.0485 | 0.2929 | 1 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0044 | 0 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.1015 | 0.3467 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0044 | 0 | 0.5 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0197 | 0.1015 | 0.3467 |
Loa Loa (eye worm) | CMGC/CDK/CDK7 protein kinase | 0.0485 | 0.2929 | 0.2929 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0044 | 0 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0485 | 0.2929 | 0.2929 |
Schistosoma mansoni | hypothetical protein | 0.0163 | 0.079 | 0.079 |
Echinococcus multilocularis | geminin | 0.0163 | 0.079 | 0.2698 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0044 | 0 | 0.5 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0197 | 0.1015 | 0.1015 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0048 | 0.0028 | 0.0028 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0044 | 0 | 0.5 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0444 | 0.2658 | 0.9074 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.7079 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 0.7079 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 1.6511 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.